Evaluating long-term antibody responses to booster doses of COVID-19 vaccines in the Pakistani population
Description
CONCLUSION: A heterologous booster dose with Pfizer-BioNTech COVID-19 vaccine following two doses of BBIBP results in increased total antibody titers, though neutralizing antibody titers may start to wane a few months after the booster dose.